Harvard Bioscience (HBIO) Can't File 10-K by Deadline Due to Preliminary Findings of Embezzled Money; Reports Prelim. Q4 Revenue of $28M
Get Alerts HBIO Hot Sheet
Revenue Growth %: -6.7%
Financial Fact:
Operating income: -813K
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that the filing of its Annual Report on Form 10-K for the year ended December 31, 2015 (the “Form 10-K”) would not occur prior to the extended March 30, 2016 deadline, and also announced preliminary unaudited revenue for the three and twelve months ended December 31, 2015.
On March 14, 2016, the Company filed a Notification of Late Filing on Form 12b-25 (the “Form 12b-25”), indicating that the filing of its Form 10-K will be delayed due to the timing of a forensic investigation initiated by the Company following its discovery, based upon preliminary findings, that an employee at Denville Scientific, Inc., one of its wholly-owned subsidiaries, appears to have embezzled money from the Company and manipulated certain records in an attempt to conceal the theft.
While the Company is continuing to diligently prepare the Form 10-K and related financial statements for filing, it has determined that it will not be in position to file the same within the prescribed 15-day extension period. This continued delay is primarily a result of a combination of the time required for the forensic accounting expert to complete its comprehensive investigation of the embezzlement, as well as the ongoing efforts of the Company’s independent registered public accounting firm to complete its audit of the Company’s consolidated financial statements and internal control over financial reporting in accordance with the standards of the U.S. Public Company Accounting Oversight Board.
As the audited financial statements continue to be finalized, the Company reports that preliminary unaudited revenue for the three and twelve months ended December 31, 2015 were $28 million and $109 million, respectively.
(Street sees Q4 revenue of $25.85 million).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Semtech (SMTC) climbs as Q4 revenue and guidance surpass expectations
- Leafly Holdings (LFLY) Appoints Jeffrey Monat and Andres Nannetti to its Board
- PayPal (PYPL) Appoint Carmine Di Sibio to its Board
Create E-mail Alert Related Categories
Corporate News, Guidance, Hot Corp. News, LitigationRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!